This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Influenza
and you are
between 1 and 8
years old
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

This study will investigate markers, mechanisms and define general predictors for immunological health by comparing influenza vaccine responses in monozygotic and dizygotic twins.

Provided treatments

  • Biological: Fluzone® standard IIV3
  • Biological: Fluzone® standard IIV3 Pediatric Dose
Tris trial is registered with FDA with number: NCT03023176. The sponsor of the trial is Stanford University and it is looking for 20 volunteers for the current phase.
Official trial title:
Protective Mechanisms Against a Pandemic Respiratory Virus: B-cell, T-cell, and General Immune Response to Seasonal Influenza Vaccine. Year 5, 2013